Detalhe da pesquisa
1.
γδ T cell antigen receptor polyspecificity enables T cell responses to a broad range of immune challenges.
Proc Natl Acad Sci U S A
; 121(4): e2315592121, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38227652
2.
Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.
Gut
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621924
3.
Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
J Hepatol
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479614
4.
A TLR7-nanoparticle adjuvant promotes a broad immune response against heterologous strains of influenza and SARS-CoV-2.
Nat Mater
; 22(3): 380-390, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717665
5.
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.
Gut
; 73(1): 156-165, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884354
6.
Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis.
Gut
; 71(1): 148-155, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33436495
7.
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.
J Hepatol
; 76(1): 107-114, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34530063
8.
Liver cirrhosis.
Lancet
; 398(10308): 1359-1376, 2021 10 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543610
9.
Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
Gastroenterology
; 160(1): 206-218.e13, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941879
10.
The Use of Rifaximin in Patients With Cirrhosis.
Hepatology
; 74(3): 1660-1673, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33421158
11.
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium.
J Hepatol
; 74(1): 200-219, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32896580
12.
Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.
Liver Int
; 41(11): 2729-2732, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34569697
13.
Improved prediction of mortality by combinations of inflammatory markers and standard clinical scores in patients with acute-on-chronic liver failure and acute decompensation.
J Gastroenterol Hepatol
; 36(1): 240-248, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32478437
14.
Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes.
J Hepatol
; 72(6): 1132-1139, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31953138
15.
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
J Hepatol
; 72(4): 688-701, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31778751
16.
Clinical Application of Kidney Biomarkers in Cirrhosis.
Am J Kidney Dis
; 76(5): 710-719, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32622560
17.
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study.
Hepatology
; 70(1): 319-333, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30810244
18.
Prevalence and short-term mortality of acute-on-chronic liver failure: A national cohort study from the USA.
J Hepatol
; 70(4): 639-647, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30590100
19.
AASLD Practice Guidance on Acute-on-chronic liver failure and the management of critically ill patients with cirrhosis.
Hepatology
; 2023 Nov 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939273
20.
Cell death markers in patients with cirrhosis and acute decompensation.
Hepatology
; 67(3): 989-1002, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29023872